PeerView Oncology
Avatar

2020 Updates on Immuno-Oncology: A Visual Exploration of Current and Emerging Pathways, Targets, and Biomarkers to Maximize the Potential of Cancer Immunotherapies

By PeerView Oncology FEATURING Nadeem Riaz
By PeerView Oncology FEATURING Nadeem Riaz
321 views
November 27, 2020
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
06:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of C…

Feat. A. Medford
41:07
Yale Cancer Center

Understanding Your Cancer Risk and Options for Cancer Prevention

Feat. V. Giri, T. Shroff
23:00
Total Health

ctDNA and MRD: Who, What, and Then What?

Feat. A. Parikh
11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
19:05
International Congress on Cancer Metastasis

Could We Cure Metastatic Breast Cancer?

Feat. L. Pusztai
21:23
2023 Evolution Conference

Comprehensive Genomic Profiling: Why Aren't We Doing It?

Feat. J. Meisel
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
20:31
Total Health

Diagnostics: Genomics for Treatment Planning of Breast Cancer

Feat. R. L. Mahtani
09:48
ecancer

ESMO 2022 on the PATHFINDER Study: A New Era of Early Cancer Detecti…

Feat. D. Schrag
14:27
ecancer

Latest in Lung Cancer Genomic Testing

Feat. S. Popat
11:26
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Bispecific

Feat. J. Gulley
20:06
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Combination Therapy

Feat. A. Patnaik
08:04
ASCO 2022 Conference Coverage

ASCO 2022 on OPTIMA Preliminary Trial: Disparity Between Ki67 Measur…

Feat. R. Stein
15:10
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

NGS in Glioblastoma: Clinically Relevant Genomics

Feat. J. Morrissette
22:52
Total Health

Breast Cancer Genetics, Genomics, and Emerging Diagnostic Tools

Feat. R. Acharya-Leon
13:16
Total Health

Universal Comprehensive Genomic Profiling and Treatment Planning

Feat. R. Salgia
20:34
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Optimizing Surgery and IO for Gliomas Using Advances in Genomics

Feat. N. Amankulor
20:12
OncoAlert

Geriatric Oncology Updates: Guidelines and Priorities for Older Pati…

Feat. L. Decoster